NCT00075192 - CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

March 31, 2006

Conditions

Prostatic Neoplasms

Interventions

DRUG

CP-675,206 and leuprolide acetate and bicalutamide

DRUG

leuprolide acetate and bicalutamide

Trial Locations (11)

Research Site, Washington D.C.

Research Site, Gallatin

Research Site, Hermitage

Research Site, Lebanon

Research Site, Murfreesboro

Research Site, Smyrna

Research Site, Nashville

Research Site, Nashville

Research Site, Nashville

Research Site, Nashville

Research Site, La Masa